Press Release Archive - 2015

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

08 Jan 2015

Antares Pharma to Present at the 33rd Annual JP Morgan Healthcare Conference
READ  

13 Jan 2015

Antares Pharma Announces Update to Quick Shot Testosterone Program
READ  

26 Jan 2015

Antares Pharma Provides Regulatory Update on Sumatriptan Injection USP
READ  

18 Feb 2015

Antares Pharma to Present at the 2015 RBC Capital Markets' Global Healthcare Conference
READ  

23 Feb 2015

Antares Pharma to Present at the Cowen and Company 35th Annual Healthcare Conference
READ  

25 Feb 2015

Antares Pharma Announces Positive Top-line Pharmakcokinetic Results From the Quickshot Phase 3 Study in Testosterone Deficient Men
READ  

05 Mar 2015

Antares Pharma To Host Fourth Quarter 2014 Operating and Financial Results Call
READ  

12 Mar 2015

Antares Pharma Reports Fourth Quarter and Full Year 2014 Operating and Financial Results
READ  

31 Mar 2015

Antares Pharma Announces FDA Approval of TEV-TROPIN 10 mg (Human Growth Hormone) Needle-Free Injector
READ  

16 Apr 2015

Antares Pharma Announces Settlement of Patent Infringement Lawsuits
READ  

27 Apr 2015

Antares Pharma Regains U.S. Marketing Rights to Otrexup for Psoriasis Indication
READ  

30 Apr 2015

Antares Pharma to Present at the Deutsche Bank Securities 40th Annual Health Care Conference
READ  

05 May 2015

Antares Pharma Announces Proposed Public Offering of Common Stock
READ  

05 May 2015

Antares Pharma to Host First Quarter 2015 Operating and Financial Results Call
READ  

06 May 2015

Antares Pharma Announces Pricing of Public Offering of Common Stock
READ  

06 May 2015

Antares Pharma to Present at the Bank of America Merrill Lynch Healthcare Conference
READ  

11 May 2015

Antares Pharma Reports First Quarter 2015 Financial and Operating Results
READ  

11 May 2015

Antares Pharma Announces Closing of Public Offering of Common Stock
READ  

28 May 2015

Antares Pharma to Present at the Jefferies 2015 Global Healthcare Conference
READ  

01 Jun 2015

Antares Pharma Announces Additional Update to QuickShot Testosterone Program
READ  

16 Jun 2015

Antares Pharma to Present at the JMP Securities Life Sciences Conference
READ  

14 Jul 2015

Antares Pharma Appoints Peter J. Graham ESQ., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
READ  

03 Aug 2015

Antares Pharma to Host Second Quarter 2015 Operating and Financial Results Call
READ  

04 Aug 2015

Antares Pharma Announces First Patients Enrolled in Quickshot Testosterone Supplemental Safety Study
READ  

10 Aug 2015

Antares Pharma Reports Second Quarter 2015 Financial and Operating Results
READ  

24 Sep 2015

Antares Pharma to Present at the Ladenburg Thalmann 2015 Healthcare Conference
READ  

28 Sep 2015

Antares Pharma Announces Publication of Quickshot Testosterone in Prestigious Health Journal
READ  

30 Oct 2015

Antares Pharma Announces Update to Quickshot Testosterone Program
READ  

03 Nov 2015

Antares Pharma Announces Enrollment Complete in Quickshot Supplemental Saftey Study QST 15-005
READ  

28 Oct 2015

Antares Pharma to Host Third Quarter Operating and Financial Results Conference Call
READ  

05 Nov 2015

Antares Pharma Reports Third Quarter 2015 Operating and Financial Results
READ  

09 Nov 2015

Antares Pharma Announces Podium Presentation of Otrexup Dose Conversation Data at American College of Rheumatology Annual Meeting
READ  

20 Nov 2015

Antares Pharma Announces Poster Presentation at the Sexual Medicine Society Scientific Annual Meeting
READ  

20 Nov 2015

Antares Pharma Announces PosterPoster Presentation at the Sexual medicine Society Scientific Annual Meeting
READ  

02 Dec 2015

Antares Pharma to Present at the 26th Annual Oppenheimer Healthcare Conference
READ  

14 Dec 2015

Antares Pharma Announces the FDA Approval of Sumatriptan Injection USP
READ